RCTs is a French and International Full-Service CRO with more than 30 years of experience and over 700 projects conducted: clinical studies from phase I to phase IV, real-life or public health impact studies, medical and administrative assessments of SNDS (National Health Data System) databases, in various therapeutic areas (oncology, diabetes, cardiology, rheumatology, infectious diseases, central nervous system, vaccines...), for drug and medical device manufacturers, as well as for academic sponsors, institutions, learned societies and patient associations. Besides, RCTs has an expertise in clinical evaluations (CEP and CER) and regulatory consulting for medical devices. It is also a stable company whose staff annual renewal rate is less than 10% and whose capital is fully owned by its 3 current Directors (Alain Baleydier, Jean-Sylvain Larguier and Frédéric Mistretta). IT tools (eCRF, IWRS, ePRO, eTMF, CTMS) are being constantly adapted to the constraints and evolutions of the business and regulations. These tools are developed and maintained by ClinInfo, our daughter company (http://www.clininfo.fr/). RCTs is also co-founder and shareholder of PSN Research LLC (http://psnresearch.com/), owned by 7 European CROs and one US CRO (France, Germany, Italy, Denmark, Spain, Netherlands, Great Britain, USA). This structure provides you with a unique added value across all these territories and even beyond, through preferred partners in countries not directly covered by PSN Research's parent companies. Specializations: Clinical studies, Pharmaco-epidemiology, Health economics, Medical Devices, Consulting, Medical Writer, Clinical Evaluation (CEP, CER), CRO, eCRF, IWRS, ePRO and eTMF.